mepivacaine and ro13-9904

mepivacaine has been researched along with ro13-9904 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brander, KA; Frutig, K; Hari, Y; Pichler, WJ; Schnyder, B; Valitutti, S; von Greyerz, S; Zanni, MP1

Other Studies

1 other study(ies) available for mepivacaine and ro13-9904

ArticleYear
HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.
    The Journal of clinical investigation, 1998, Oct-15, Volume: 102, Issue:8

    Topics: Antigen Presentation; Antigen-Presenting Cells; Calcium Signaling; Ceftriaxone; Dose-Response Relationship, Drug; Down-Regulation; Haptens; HLA Antigens; Humans; Lidocaine; Mepivacaine; Models, Immunological; Receptors, Antigen, T-Cell, alpha-beta; Sulfamethoxazole; Superantigens; T-Lymphocytes

1998